Effect of Continued Nutritional Support at Hospital Discharge on Mortality, Frailty, Functional Outcomes and Recovery

NCT ID: NCT04926597

Last Updated: 2024-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-05

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to compare the sustained post-discharge nutritional support to reach individual energy and protein goals to usual care home nutrition in medical patients at nutritional risk.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Malnutrition is a strong and independent long-term risk factor for mortality, rehospitalisation and functional decline, particularly in the elderly, polymorbid medical patient population. The randomized-controlled Effect of early nutritional support on Frailty, Functional Outcomes and Recovery of malnourished medical inpatients Trial (EFFORT, Lancet 2019) included 2028 patients in eight Swiss hospitals and found that nutritional support during the inhospital stay reduces very efficiently the risk for complications and mortality with numbers needed to treat (NNT) of 23 and 37, respectively.

Yet, the nutritional intervention was not continued after hospital discharge of patients and long-term follow-up data of patients showed a lack of sustained effect of the initial nutritional support strategy. There is a current lack of trial data investigating whether long-term use of nutritional support has a sustained effect on clinical outcomes in this patient population. This study is to compare the continuous use of nutritional support with the use of approved oral nutritional supplements to reach protein and energy goals and to analyze whether medical patients at nutritional risk show a sustained benefit from long-term nutritional support after hospital discharge, and why and how nutritional support affects the course of disease from a mechanistic physio-pathological standpoint.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malnutrition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Pragmatic, single blinded, open label randomised-controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
This trial is single blinded (regarding outcome assessment)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group: individualized nutritional support

Intervention group patients will receive individualized nutritional support to reach energy and protein goals with the support of an experienced, unblinded dietician and with use of oral nutritional supplements (ONS) as needed

Group Type EXPERIMENTAL

nutritional supplement

Intervention Type DIETARY_SUPPLEMENT

daily use of one or more specific oral nutritional supplement with high energy/protein content (i.e., Resource Ultra, Resource 2.0 (Fibre), Resource Ultra Fruit).

individualized nutritional guidelines

Intervention Type OTHER

nutritional plan supervised by an experienced study dietician based on the usual home nutrition with possibility to increase intake by adaptation to patient preferences, between meal snaking and food enrichment/fortification. Every 2-4 weeks phone call by unblinded study dietician to follow nutritional intervention.

Control group: general information on healthy food habits

Control group patients will receive nutritional counselling (general information on healthy food habits) at discharge, but no nutritional support strategy will be used during follow-up

Group Type OTHER

general nutritional information

Intervention Type OTHER

general information about health food behavior upon hospital discharge

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

nutritional supplement

daily use of one or more specific oral nutritional supplement with high energy/protein content (i.e., Resource Ultra, Resource 2.0 (Fibre), Resource Ultra Fruit).

Intervention Type DIETARY_SUPPLEMENT

individualized nutritional guidelines

nutritional plan supervised by an experienced study dietician based on the usual home nutrition with possibility to increase intake by adaptation to patient preferences, between meal snaking and food enrichment/fortification. Every 2-4 weeks phone call by unblinded study dietician to follow nutritional intervention.

Intervention Type OTHER

general nutritional information

general information about health food behavior upon hospital discharge

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Informed Consent as documented by signature
* Adult (age ≥18 years), medical patients
* Nutritional risk screening using the Nutritional Risk Screening (NRS): total score ≥3 points consisting of ≥1 points for impairment of the nutritional status \[weight loss \>5% in 3 month or food intake of 50-75% in the last week before hospital admission\] plus ≥1 for the severity of the disease (i.e., cancer, chronic kidney disease, chronic heart failure, COPD) and other chronic diseases according to the definition of the "National Center for Chronic Disease Prevention and Health Promotion": Chronic diseases are defined broadly as conditions that last 1 year or more and require ongoing medical attention or limit activities of daily living or both .

Exclusion Criteria

* after surgery
* unable to ingest oral nutrition
* need for long-term nutrition,
* terminal condition
* acute pancreatitis or acute liver failure
* patients discharged to a nursing home
* patients unlikely to comply with nutritional support treatment (e.g., dementia)
* COVID-Hospitalisation requiring intensive care
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Philipp Schuetz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Philipp Schuetz

Prof. Dr. med.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philipp Schuetz, Prof. Dr. med.

Role: PRINCIPAL_INVESTIGATOR

Kantonsspital Aarau, University Department of Internal Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitari Vall Hebron de Barcelona

Barcelona, , Spain

Site Status RECRUITING

Hospital Universitario de Getafe

Getafe, , Spain

Site Status RECRUITING

Complejo AComplejo Asistencial Universitario de León

León, , Spain

Site Status RECRUITING

Hospital U. Gregorio Marañón de Madrid

Madrid, , Spain

Site Status RECRUITING

Hospital Universitario Regional de Málaga

Málaga, , Spain

Site Status RECRUITING

Hospital Clínico Universitario de Valladolid

Valladolid, , Spain

Site Status RECRUITING

Spital Zofingen

Zofingen, Canton of Aargau, Switzerland

Site Status COMPLETED

Spital Emmental Burgdorf

Burgdorf, Canton of Bern, Switzerland

Site Status COMPLETED

Spital Thun

Thun, Canton of Bern, Switzerland

Site Status RECRUITING

Spital Lachen

Lachen, Canton of Schwyz, Switzerland

Site Status RECRUITING

Kantonsspital Münsterlingen

Münsterlingen, Thurgau, Switzerland

Site Status RECRUITING

Kantonsspital Aarau, University Department of Internal Medicine

Aarau, , Switzerland

Site Status RECRUITING

Bern University Hospital, Department of General Internal Medicine

Bern, , Switzerland

Site Status COMPLETED

Kantonsspital Lucerne, Department of Internal Medicine

Lucerne, , Switzerland

Site Status COMPLETED

Kantonsspital Sankt Gallen

Sankt Gallen, , Switzerland

Site Status COMPLETED

Klinik Hirslanden Zürich

Zurich, , Switzerland

Site Status COMPLETED

Stadtspital Zürich

Zurich, , Switzerland

Site Status COMPLETED

Universitätsspital Zürich

Zurich, , Switzerland

Site Status COMPLETED

Countries

Review the countries where the study has at least one active or historical site.

Spain Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Philipp Schuetz, Prof. Dr. med.

Role: CONTACT

+41 (0) 62 838 9524

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rosa Burgos Peláez, Dr. med.

Role: primary

Leocardio Rodríguez Mañas, Dr. med.

Role: primary

María Ballesteros, Dr. med.

Role: primary

Christina Cuerda, Dr. med.

Role: primary

Gabriel Olveira Fuster, Dr. med.

Role: primary

Daniel de Luis Román, Dr. med.

Role: primary

Thomas Zehnder, Dr. med.

Role: primary

+41 33 226 26 49

Thomas Bregenzer, Dr. med.

Role: primary

+41 55 451 31 03

Vojtech Pavlicek, Dr. med.

Role: primary

Philipp Schuetz, Prof. Dr. med.

Role: primary

+41 (0) 62 838 9524

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-00278; ex20Schuetz

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cater With Care Effect Study
NCT02213393 COMPLETED NA